Sweta Agrawal: Expanding Access to Life-Changing PNH Therapy in Nepal
Sweta Agrawal, Program Coordinator of Nepal at The Max Foundation, shared The Max Foundation’s post on LinkedIn:
“I am honoured to work with Dr. Lama and learn so much from him.
I have met and interacted with PNH patients at Patan Hospital and the results are just amazing.
They share their experiences and each one is doing great on medication.”
The Max Foundation shared a post on LinkedIn:
“For physicians like Dr. Mipsang Lama in Nepal, there was a time when the rare and devastating blood disorder of Paroxysmal Nocturnal Hemoglobinuria (PNH) could be identified but not truly treated.
Care meant repeated transfusions, temporary stabilization, and watching patients live with constant uncertainty.
Then, thanks to our partnership with Novartis Global Health and the International PNH Interest Group, access to treatment and training changed that!
Within weeks, patients began regaining strength.
Conversations shifted from survival to possibility.
For Dr. Lama, it was more than a clinical change.
It was the ability to finally offer hope alongside care.
He shared: ‘To those working in global health and rare disease access, your work has a deeply human impact.
PNH may be rare, but the suffering it causes is real and significant.
Today, for the first time, we can say with confidence that ‘it is treatable.”
You can read more about the impact access is having in Nepal.”
Stay updated with Hemostasis Today.
-
May 16, 2026, 14:58Nathan Connell: The Changing Landscape of von Willebrand Disease Diagnosis and Management
-
May 16, 2026, 14:51Stacey McGeown: Honoured to Host a Rare Bleeding Disorders Event That Meant Everything
-
May 16, 2026, 14:23Tom Ferry: ECMO Weaning Begins at the Circuit, Not the Bedside
-
May 16, 2026, 14:18Irina Portier: How Heme-Driven Platelet Signaling Worsens Malaria Neuropathogenesis
-
May 16, 2026, 14:05Amir Sedighi: The Hidden Risk in Global Plasma Supply Strategy
-
May 16, 2026, 14:03Ali Saad Al-shammari: Exploring the Role of SGLT2 Inhibitors After TAVI
-
May 16, 2026, 13:49Priscilla Chassama: Expanding Healthcare Access for Children Living with Sickle Cell Disease in Geita
-
May 16, 2026, 12:00Anna Oleksiak: Is Thrombocytopenia in Critical Cardiac Care HIT?
-
May 16, 2026, 11:29Kim Gannon: Women Have Unique Stroke Risk Factors and The Warning Signs Can Look Different